Infection control specialists constantly debate the effectiveness of traditional hospital safety strategies. MRSA infection prevention often relies on contact precautions and active surveillance. During the COVID-19 pandemic, many hospitals suspended these protocols due to operational strain. A recent study in 121 VA hospitals examined the consequences of these policy shifts.

Initially, discontinuation of screening or isolation protocols appeared to correlate with higher infection rates. However, these associations significantly weakened after researchers adjusted for the baseline burden of MRSA. Furthermore, mixed-effects models showed no statistically significant increase in healthcare-associated infections. This suggests that facility-specific factors and pandemic-related hygiene practices likely mitigated the expected rise in cases.

Modernizing MRSA Infection Prevention Protocols

Clinicians should interpret these findings as a call for more flexible, evidence-based infection control. Traditional bundles remain valuable, yet they are not the sole drivers of success. Consequently, facilities might benefit from prioritizing institutional culture and baseline data over rigid universal mandates. Moreover, the study highlights how unmeasured practices, such as enhanced PPE use, significantly influence transmission dynamics.

Frequently Asked Questions

How did the pandemic impact MRSA precaution policies?

Many facilities suspended active surveillance and contact precautions for colonized or infected patients. This occurred due to the immense pressure on healthcare staff and clinical resources during peak waves.

Were the infection rate increases significant after data adjustment?

No. While simple models suggested a link between policy removal and higher infection rates, the associations became non-significant after adjusting for baseline infection burdens and hospital-specific factors.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Khader K et al. Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy. Clin Infect Dis. 2026 Mar 13. doi: undefined. PMID: 41823982.

CDC. Infection Control Guidance: Preventing Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities. June 2025.

WHO. Global action plan and monitoring framework for infection prevention and control (2024-2030). 2024.